title: Cisapride and cystic fibrosis.
authors.forename: H L
authors.initials: HL
authors.lastname: Smith
authors.forename: D J
authors.initials: DJ
authors.lastname: Handy
authors.forename: P H
authors.initials: PH
authors.lastname: Weller
authors.forename: I W
authors.initials: IW
authors.lastname: Booth
mesh_terms: D000293:Adolescent; D002648:Child; D020117:Cisapride; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000150:complications*; D004311:Double-Blind Method; D005260:Female; D005541:Forced Expiratory Volume; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D008297:Male; D010880:Piperidines / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology*
chemical_list: D010880:Piperidines; D012702:Serotonin Antagonists; D020117:Cisapride